Applications of protein ubiquitylation and deubiquitylation in drug discovery
Journal of Biological Chemistry · 2024
DOI: 10.1016/j.jbc.2024.107264 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Yilin Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Life Sciences Institute, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Drug Discovery, Ubiquitination, Proteolysis, Proteasome Endopeptidase Complex. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The ubiquitin (Ub)-proteasome system (UPS) is the major machinery mediating specific protein turnover in eukaryotic cells. By ubiquitylating unwanted, damaged, or harmful proteins and driving their degradation, UPS is involved in many important cellular processes. Several new UPS-based technologies, including molecular glue degraders and PROTACs (proteolysis-targeting chimeras) to promote protein degradation, and DUBTACs (deubiquitinase-targeting chimeras) to increase protein stability, have been developed. By specifically inducing the interactions between different Ub ligases and targeted proteins that are not otherwise related, molecular glue degraders and PROTACs degrade targeted proteins via the UPS; in contrast, by inducing the proximity of targeted proteins to deubiquitinases, DUBTACs are created to clear degradable poly-Ub chains to stabilize targeted proteins. In this review, we summarize the recent research progress in molecular glue degraders, PROTACs, and DUBTACs and their applications. We discuss immunomodulatory drugs, sulfonamides, cyclin-dependent kinase-targeting molecular glue degraders, and new development of PROTACs. We also introduce the principle of DUBTAC and its applications. Finally, we propose a few future directions of these three technologies related to targeted protein homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Life Sciences Institute, Zhejiang University, Hangzhou, China.
- Life Sciences Institute, Zhejiang University, Hangzhou, China; Center for Life Sciences, Shaoxing Institute, Zhejiang University, Shaoxing, China.
- Life Sciences Institute, Zhejiang University, Hangzhou, China; Center for Life Sciences, Shaoxing Institute, Zhejiang University, Shaoxing, China; Cancer Center, Zhejiang University, Hangzhou, China. Electronic address:…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Chen, Y., Xue, H., & Jin, J. (2024). Applications of protein ubiquitylation and deubiquitylation in drug discovery. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107264
Vancouver
Chen Y, Xue H, Jin J. Applications of protein ubiquitylation and deubiquitylation in drug discovery. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107264
BibTeX
@article{Chen2024,
author = {Chen, Yilin and Xue, Haoan and Jin, Jianping},
title = {Applications of protein ubiquitylation and deubiquitylation in drug discovery},
journal = {Journal of Biological Chemistry},
year = {2024},
doi = {10.1016/j.jbc.2024.107264}
}
EUVIMED